multiple inhalers on a white background Researchers explored the association between dry powder inhaler technique errors and exacerbations and health status in patients with COPD. Severe COPD ...

Scientific research will highlight advances in dry powder inhaler (DPI) platform products, patient-centric design and ...

New triple therapy: The FDA approved AstraZeneca’s Breztri Aerosphere for asthma patients 12 and older, offering a single inhaler combining ICS/LABA with a LAMA for maintenance treatment. Device ...

Inhaler technique informs health care outcomes in COPD management and should be a primary focus in patient education priorities. Jeffrey D. Dunn, PharmD, MBA: [Let’s talk about] patient perspective ...

Tyvaso DPI is a drug-device combination therapy that consists of a dry powder formulation of treprostinil and a small, portable, dry powder inhaler. The Food and Drug Administration (FDA) has approved ...

Please provide your email address to receive an email when new articles are posted on . “Many health care systems are discussing a transition to dry-powder inhalers that have a lower carbon footprint ...

Researchers conducted an observational study using real‑world data to compare the effectiveness and safety of initiating three fixed‑dose long‑acting muscarinic antagonist (LAMA)-long‑acting beta‑2 ...

Inhalers deliver medication directly to the lungs for conditions like asthma and COPD, using devices such as metered-dose inhalers (MDIs), dry powder inhalers (DPIs), or soft mist inhalers (SMIs).

Chronic obstructive pulmonary disease (COPD) is a chronic lung condition characterized by loss of lung elasticity, which leads to dysfunctional gaseous exchange. COPD is the third leading cause of ...

Flovent, a popular corticosteroid inhaler used to treat asthma, is no longer available. The global manufacturer, Glaxo Smith Kline (GSK), announced in May that the medications — Flovent HFA, a metered ...